Over the past six years, Dr. Teresa Lavoie has developed, managed, and overseen the sale of patent portfolios worth more than $20bn in deal value. Her international practice focuses on strategic patent counseling, prosecution, and portfolio development advice, including patent opinions, due diligence, freedom-to-operate analyses, and life cycle management strategies. Dr. Lavoie’s clients range from start-up and emerging companies developing life-saving therapeutics and diagnostics to academic and research institutions inventing disruptive platform technologies for the biotechnology and biopharma industries. She has extensive experience in the areas of small-molecule and biologic pharmaceuticals (including antibody technologies and immunotherapies, such as CAR-T therapies), drug formulation and drug delivery technologies, diagnostics, clean and alternative (animal- and environmentally-friendly) food technologies, protein biochemistry and engineering, cell systems engineering, nanotechnologies, plant biotechnology and genomics, and green/environmental chemistries. Dr. Lavoie also has significant transactional experience in various aspects of IP licensing, including sponsored research, feasibility, and development and commercialization agreements.
Dr. Lavoie’s clients are located in the major biotechnology, academic/research institution, and start-up clusters around the country and the world, including San Francisco, Cambridge/Boston, and San Diego. Representative clients include: Array BioPharma, Avanir Pharmaceuticals, Carmot Therapeutics, Cell Design Labs, Compass Therapeutics, Concert Pharmaceuticals, Cocoon Biotech, IFM Therapeutics, Impossible Foods, Loxo Oncology, Melinta Therapeutics, Onyx Pharmaceuticals, and Samumed.
In addition to her work on behalf of clients, Dr. Lavoie runs the firm’s industry-leading Patent Prosecution Boot Camp, an immersive 2.5-day program designed to intensely train junior attorneys and patent agents of the firm and firm clients in the skills of strategic and value-focused patent prosecution.
Dr. Lavoie’s passion for advancing women in the legal industry and her involvement in the recruitment, retention, and advancement of women in both STEM and law has been a hallmark of her legal practice and volunteer commitments throughout her career. She is currently Chair of Fish & Richardson’s EMPOWER Initiative. EMPOWER (Enrichment, Mentorship, Partnering, Opportunities, Wisdom, Excellence, and Responsibility) seeks to address issues of unique importance to women in the legal profession and provide expanded professional and business development opportunities, mentoring, training, and support to the firm’s female legal staff. She has also been a member of the firm’s Compensation Committee for four years. In addition, Dr. Lavoie serves as Co-Chair of the Equity Committee for Minnesota Women Lawyers, a volunteer organization dedicated to advancing the success of women attorneys and striving for a just society.
Recently, Dr. Lavoie endowed The Anna E. Lavoie Memorial Lectureship at Providence College in tribute to her late mother. Its purpose is to encourage undergraduates to consider a wide array of career paths in the sciences through interaction with distinguished scientists and other professionals. She is also an Adjunct Professor at the University of Minnesota Law School, teaching Biotechnology Patent Law.
Prior to joining Fish, Dr. Lavoie worked as an Intellectual Property Specialist for Epix Pharmaceuticals, Inc. (1996-2000), as a Special Projects Coordinator for Environmental Waste Management Associates, Inc. (1995-1996), and as a Research Assistant at Princeton University (1990-1995).
April 7th, 2019
Chinese Antibody Society 3rd Annual Conference
February 21, 2019
Fish & Richardson’s Dr. Teresa Lavoie Receives 2019 “Diversity Leader” Award
January 28th, 2019 | 8:00 am GMT
IAM: Pharma & Biotech IP Seminar
September 27, 2018
Fish & Richardson Announces 13 Principals Named 2018 “Life Sciences Stars” by LMG Life Sciences
October 17th, 2018 | 5:00 pm EDT
Xconomy: Boston’s Life Science Disruptors
October 14th, 2018
Licensing Executive Society (LES) 2018 Annual Meeting
October 3rd, 2018 | 10:45 am EDT
Crush Life Sciences: Deal Meeting 2018
July 20th, 2018 | 8:30 am PDT
American Chemical Society 21st Annual MedChem Symposium
February 7th, 2018 | 5:00 pm CST
Minnesota Lawyer 2017 Attorney of the Year
July 14th, 2017 | 8:30 am PDT
American Chemical Society: 20th Annual San Diego Medchem Symposium
April 4th, 2017 | 4:00 pm EDT
Boston Seminar Series | IP and the Business of Biopharma: Lessons Learned (Sometimes the Hard Way)
November 12th, 2012
Bio Europe 2012